SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.84+2.8%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (14629)2/11/1998 6:59:00 PM
From: Andrew H  Read Replies (1) of 32384
 
>>and we now have determined that Targretin is effective in the treatment of well-established tumors," according to Richard Heyman, Ph.D., Senior Director of Ligand's department of Retinoid Research.<<

This is big news, however the market and the barnyard leaders respond. More than twice as effective as the leading treatment!! And with virtually none of the nasty side effects. If it doesn't move the stock now, it will before too long. Maybe it can help that rodent, Mr. Tucker?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext